» Articles » PMID: 22847008

Role of P63 in Development, Tumorigenesis and Cancer Progression

Overview
Publisher Springer
Specialty Oncology
Date 2012 Aug 1
PMID 22847008
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

The p53-related protein p63 has pleiotropic functions, including cell proliferation, survival, apoptosis, differentiation, senescence, and aging. The p63 gene is expressed as multiple isoforms that either contain an N-terminal p53-homologous transactivation domain (TAp63) or that lack this domain (ΔNp63). Multiple studies have demonstrated that p63 plays a crucial role in stratified epithelial development, and have shown the importance of p63 for maintaining proliferation potential, inducing differentiation, and preventing senescence. Additionally, much research focuses on the role of p63 in cancer progression. Clinical evidence suggests that p63 may play a role in inhibiting metastasis. Similarly, genetic mice models together with cell culture data strongly indicate that p63 deficiency may be a causative factor for metastatic spread. Moreover, the role of p63 in cancer metastasis has been shown to be greatly related to the ability of mutant p53 to promote cancer malignancy. However, there is still much confusion as to what the role of each specific isoform is. In this review, we highlight some of the major findings in the current literature regarding the role of specific p63 isoforms in development, tumorigenesis, and particularly in cancer metastasis.

Citing Articles

Detection of Oral Submucous Fibrosis at the Crossroads of Altering Nucleogeometry, Nuclear Spatial Distribution and Nuclear Molecular Abundance.

Chakraborti S, Paul R, Pal M, Chatterjee J, Das R Indian J Otolaryngol Head Neck Surg. 2025; 77(2):929-938.

PMID: 40070771 PMC: 11890828. DOI: 10.1007/s12070-024-05305-3.


Significance of Biogenetic Markers in Giant Cell Tumor Differentiation and Prognosis: A Narrative Review.

Taqi M, Ul Rasool H, Zaka Haider M, Al Muderis M Diagnostics (Basel). 2025; 15(1.

PMID: 39795567 PMC: 11719472. DOI: 10.3390/diagnostics15010039.


Canine mammary tumors as a promising adjunct preclinical model for human breast cancer research: similarities, opportunities, and challenges.

Bhutta Z, Choi K Arch Pharm Res. 2025; 48(1):43-61.

PMID: 39752109 DOI: 10.1007/s12272-024-01524-y.


Let-7 family regulates HaCaT cell proliferation and apoptosis via the ΔNp63/PI3K/AKT pathway.

Li M, Ding Y, Tuersong T, Chen L, Zhang M, Li T Open Med (Wars). 2024; 19(1):20240925.

PMID: 38584846 PMC: 10997002. DOI: 10.1515/med-2024-0925.


Potential Immunohistochemical Biomarkers for Grading Oral Dysplasia: A Literature Review.

Zdrojewski J, Nowak M, Nijakowski K, Jankowski J, Scribante A, Gallo S Biomedicines. 2024; 12(3).

PMID: 38540190 PMC: 10967812. DOI: 10.3390/biomedicines12030577.


References
1.
Rinne T, Spadoni E, Kjaer K, Danesino C, Larizza D, Kock M . Delineation of the ADULT syndrome phenotype due to arginine 298 mutations of the p63 gene. Eur J Hum Genet. 2006; 14(8):904-10. DOI: 10.1038/sj.ejhg.5201640. View

2.
Mills A, Zheng B, Wang X, Vogel H, Roop D, Bradley A . p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature. 1999; 398(6729):708-13. DOI: 10.1038/19531. View

3.
Ihrie R, Marques M, Nguyen B, Horner J, Papazoglu C, Bronson R . Perp is a p63-regulated gene essential for epithelial integrity. Cell. 2005; 120(6):843-56. DOI: 10.1016/j.cell.2005.01.008. View

4.
Matos I, Dufloth R, Alvarenga M, Zeferino L, Schmitt F . p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas. Virchows Arch. 2005; 447(4):688-94. DOI: 10.1007/s00428-005-0010-7. View

5.
Ferretti E, Li B, Zewdu R, Wells V, Hebert J, Karner C . A conserved Pbx-Wnt-p63-Irf6 regulatory module controls face morphogenesis by promoting epithelial apoptosis. Dev Cell. 2011; 21(4):627-41. PMC: 3199312. DOI: 10.1016/j.devcel.2011.08.005. View